SHERWIN STEPHEN A bought NBIX
May 29, 2024 · Form 4 insider transaction
SHERWIN STEPHEN A bought 25,000 shares of Neurocrine Biosciences, Inc. at $42.76 per share, a transaction worth $1.07M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$42.76
Total value
$1.07M
InsiderSHERWIN STEPHEN A
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 29, 2024
Filing dateMay 30, 2024
Shares owned after51,504
OwnershipDirect
10b5-1 planNo
AmendedNo